Evidence map›Paper›PMID 30611192›Full record

Trial reportBMC infectious diseases2019

Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort.

Kristina L Bajema, Ingrid V Bassett, Sharon M Coleman, Douglas Ross, Kenneth A Freedberg, Anna Wald, Paul K Drain

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01188941 (Linkage and Retention), which is not on this map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01188941 nacompletednot on this map

Linkage and Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa

TypeinterventionalSponsorMassachusetts General HospitalRan2010 to 2015Enrolled1,899ConditionsHIVArmsHealth System Navigator
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics.European respiratory review : an official journal of the European Respiratory Society · 2024
    Pooled it
  2. A systematic review of the number needed to screen for active TB among people living with HIV.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2021
    Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Detection of AerosolizedOpen forum infectious diseases · 2025
    Article
  9. Tuberculosis and HIV coinfection: Progress and challenges towards reducing incidence and mortality.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy-Accessing Participants: Incidence, Clinical Course, and Outcomes.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  19. Pathogens (Basel, Switzerland) · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Kristina L BajemaDepartment of Medicine, University of Washington, 1959 NE Pacific St., Box 356429, Seattle, WA, 98195, USA. kbajema@uw.edu.ORCID http://orcid.org/0000-0002-3229-5590
Ingrid V BassettDepartment of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston University School of Public Health, Boston, USA.
Sharon M ColemanBoston University School of Public Health, Boston, USA.
Douglas RossDepartment of Medicine, St. Mary's Hospital, Durban, South Africa.
Kenneth A FreedbergDepartment of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston University School of Public Health, Boston, USA.
Anna WaldDepartments of Medicine, Epidemiology, and Laboratory Medicine, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, USA.
Paul K DrainDepartments of Medicine, Global Health, and Epidemiology, University of Washington, Seattle, USA.
Boston University · USUniversity of Washington · USSeattle Pacific University · USSt. Mary’s Hospital · ZA

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI RAJESH T GANDHI · 2004 to 2026
$94.4M
Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
Optimizing HIV Care in Less Developed CountriesR01AI058736 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Kenneth Alan Freedberg, Emily Parker Hyle · 2004 to 2026
$21.5M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
PROGRAM FOR AIDS CLINICAL RESEARCH TRAINING (PACRT)T32AI007433 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARK J SIEDNER · 1992 to 2026
$11.4M
Linkage & Retention: A Randomized Trial to Optimize HIV/TB Care in South AfricaR01MH090326 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BASSETT, INGRID VALERIE · 2010 to 2014
$2.9M
Clinic-based Screening to Prevent HIV-associated Cryptococcal MortalityK23AI108293 · NIAID · UNIVERSITY OF WASHINGTON · PI DRAIN, PAUL K · 2014 to 2018
$928k
FIC NIH HHS R24 TW007988NIAID NIH HHS K23 AI108293NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI058736NIAID NIH HHS T32 AI007044NIAID NIH HHS T32 AI007433NIH HHS T32 AI007044NIMH NIH HHS R01 MH090326
6 · The paper itself

Abstract

backgroundSubclinical tuberculosis is an asymptomatic disease phase with important relevance to persons living with HIV. We describe the prevalence, clinical characteristics, and risk of mortality for HIV-infected adults with subclinical tuberculosis.

methodsUntreated adults with HIV presenting for outpatient care in Durban, South Africa were screened for tuberculosis-related symptoms and had sputum tested by acid-fast bacilli smear and tuberculosis culture. Active tuberculosis and subclinical tuberculosis were defined as having any tuberculosis symptom or no tuberculosis symptoms with culture-positive sputum. We evaluated the association between tuberculosis disease category and 12-month survival using Cox regression, adjusting for age, sex, and CD4 count.

resultsAmong 654 participants, 96 were diagnosed with active tuberculosis disease and 28 with subclinical disease. The median CD4 count was 68 (interquartile range 39-161) cells/mm

conclusionsNearly one-quarter of tuberculosis cases among HIV-infected adults were subclinical, which was characterized by an intermediate degree of immunosuppression. Although there was no significant difference in survival, anti-tuberculous treatment of subclinical cases was common.

trial registrationProspectively registered on ClinicalTrials.gov , NCT01188941 (August 26, 2010).

Indexed as

AdultAnti-Retroviral AgentsAntitubercular AgentsAsymptomatic InfectionsBlack PeopleCohort StudiesFemaleFollow-Up StudiesHIVHIV InfectionsHumansInfection ControlMaleMiddle AgedPrevalencePrognosisAnti-Retroviral AgentsAntitubercular AgentsAIDS-related opportunistic infectionsDisease progressionHIVSubclinical infectionsTuberculosis

Identifiers

PMID30611192
PMCPMC6321698
OpenAlexW2914383239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.